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Neurotransmitter release and hormonal secretion are highly regulated processes culminating in the calcium-dependent
fusion of secretory vesicles with the plasma membrane. Here, we have identified a role for phosphatidylinositol 3-kinase
C2 (PI3K-C2) and its main catalytic product, PtdIns3P, in regulated exocytosis. In neuroendocrine cells, PI3K-C2 is
present on a subpopulation of mature secretory granules. Impairment of PI3K-C2 function specifically inhibits the
ATP-dependent priming phase of exocytosis. Overexpression of wild-type PI3K-C2 enhanced secretion, whereas trans-
fection of PC12 cells with a catalytically inactive PI3K-C2 mutant or a 2xFYVE domain sequestering PtdIns3P abolished
secretion. Based on these results, we propose that production of PtdIns3P by PI3K-C2 is required for acquisition of
fusion competence in neurosecretion.
INTRODUCTION
The analysis of the molecular mechanism controlling neuro-
exocytosis has been greatly helped by studies on neurose-
cretory cells (Dunn and Holz, 1983; Sarafian et al., 1987;
Martin and Walent, 1989; Monck and Fernandez, 1994; Ret-
tig and Neher, 2002). Early work has shed light on two major
steps consisting of the reversible ATP-dependent priming of
docked granules followed by their Ca2-driven fusion with
the plasma membrane and release of the granule content
(Holz et al., 1989; Hay and Martin, 1992). The spatiotemporal
control of intracellular Ca2 concentration together with
capacitance measurements has allowed the identification of
distinct pools of chromaffin granules involved in these dis-
tinct steps (Rettig and Neher, 2002). Further electrophysio-
logical and biochemical approaches, such as the reconstitu-
tion of secretion in permeabilized neurosecretory cells
(Martin and Walent, 1989), have highlighted the role of key
factors involved in these two processes. Cytosolic and mem-
brane proteins have been linked to priming and fusion,
including the mammalian orthologues of the Caenorhabditis
elegans UNC13 and UNC18 gene products, synaptotagmins,
and members of the SNARE family and associated proteins
(Jahn and Sudhof, 1999; Burgoyne et al., 2001; Brose and
Rosenmund, 2002; Rettig and Neher, 2002).
In contrast, less is known about the contribution of lipid
dynamics during these processes with the exception of phos-
phatidic acid and phosphatidylinositol (4,5)-bisphosphate
[PtdIns(4,5)P2]. The former is produced by phospholipase D,
which is essential for secretion in neurons (Humeau et al.,
2001) and in neuroendocrine cells (Vitale et al., 2001). The
inhibition of Ca2-dependent catecholamine release after
depletion of phosphatidylinositol highlighted the role of
phosphoinositides during the secretory events (Eberhard et
al., 1990). Moreover, phosphatidylinositol transfer protein
and phosphatidylinositol-4-phosphate 5 kinase (PI4P5K)
were shown to be required for the ATP-dependent priming
of secretory granules in PC12 cells (Hay and Martin, 1993;
Hay et al., 1995). In addition, phosphatidylinositol 4-kinase
(PI4K), an integral membrane protein of chromaffin granules
and synaptic vesicles, is required for their exocytosis
(Wiedemann et al., 1996). Finally, the maintenance of a
plasma membrane pool of PtdIns(4,5)P2 was suggested to be
important for the last step of exocytosis (Holz et al., 2000;
Cremona and De Camilli, 2001; Osborne et al., 2001).
Phosphatidylinositol 3-kinases (PI3K) have recently been
shown to be involved in a variety of cellular functions,
including cell migration (Maffucci et al., 2005), axonal guid-
ance (Ming et al., 1999), long-term depression (Daw et al.,
2002), and programmed cell death (Brunet et al., 2001). How-
ever, a direct involvement of this class of enzymes and their
lipid products in neuroexocytosis has been questioned
(Chasserot-Golaz et al., 1998; Milosevic et al., 2005), based on
little or no observed inhibition of synaptosomal or neurose-
cretory cell exocytosis by the PI3K inhibitors wortmannin
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and LY294002 (Wiedemann et al., 1996; Martin et al., 1997;
Wiedemann et al., 1998). However, at the neuromuscular
junction, wortmannin was shown to inhibit both spontane-
ous and evoked quantal neurotransmitter release (Hong and
Chang, 1999). In contrast, high doses of LY294002 were
shown to inhibit synaptic vesicle recycling and to increase
spontaneous acetylcholine release on the same preparation
(Rizzoli and Betz, 2002), raising questions about the suscep-
tibility of certain types of synapses to these inhibitors and on
the type of lipid kinases involved.
MATERIALS AND METHODS
Antibodies
We used affinity purified polyclonal antibody against PI3K-C2 (Arcaro et al.,
2000), anti-hGH (Sigma), anti-Syt I (Matthew et al., 1981), anti-P18 (Wendler et
al., 2001), anti-EEA1 (a kind gift from H.T. McMahon) and anti-clathrin heavy
chain (Transduction Laboratories).
Catecholamine secretion from adrenal chromaffin cells
Chromaffin cells were prepared from bovine adrenal glands as previously
described (Meunier et al., 2002). Intact cells were washed briefly once with
buffer A (mM): NaCl, 145; KCl, 5, Na2HPO4, 1.2; glucose, 10; HEPES-NaOH,
20 (pH 7.4) and stimulated for 20 min by carbachol (100 M; Sigma) in the
presence of 2 mM CaCl2 or by depolarisation with high K modified buffer A
(mM): KCl, increase to 60; NaCl decreased to 90 and 2 mM CaCl2. For
permeabilization experiments, chromaffin cells were incubated with 20 M
digitonin (Novabiochem) in KGEP buffer (mM): K-glutamate, 139; glucose, 5;
EGTA, 5; and PIPES-NaOH, 20 (pH 6.7) for 10 min with or without addition
of antibodies. The supernatant was then discarded and release was immedi-
ately triggered for 5 min in four different conditions: KGEP alone, KGEP
containing 20 M free Ca2, KGEP containing 2 mM free Mg2 and 2 mM
ATP and KGEP containing 2 mM free Mg2, 2 mM ATP and 20 M free Ca2
in the continuous presence of inhibitors or antibodies. Aliquots of the super-
natant were taken at the end of each experiment and cells were lysed with 1%
(vol/vol) Triton X-100 (Sigma). Both sets of samples were assayed fluorimetri-
cally for catecholamines, and the amount released expressed as a percentage
of the total catecholamine content of the cells (Burgoyne, 1992). Plotted data
are representative of experiments carried out in quadruplicate and performed
at least four times.
Gel electrophoresis and immunoblotting
Protein samples (20–50 g) were prepared as previously described (Gasman
et al., 1998), boiled for 3 min in SDS sample buffer containing -mercapto-
ethanol and analyzed on 12% SDS-polyacrylamide gels. Proteins were trans-
ferred onto nitrocellulose (0.2 m), blocked in phosphate-buffered saline
(PBS) containing 3% milk (wt/vol), probed overnight at 4°C with the indi-
cated antibodies and detected with horseradish peroxidase-conjugated sec-
ondary antibody (1:2000; Dako) for 1 h followed by enhanced chemolumines-
cence (SuperSignal; Pierce).
Phosphoinositide kinase activity
Lipid kinase assays were performed in a total volume of 50 l containing 20
mM Tris-HCl (pH 7.5), 100 mM NaCl and 0.5 mM EGTA. Phosphatidylino-
sitol (10 mg/ml in 5 mM HEPES-NaOH, pH 7.4) was sonicated and preincu-
bated with each sample at a final dilution of 200 g/ml for 10 min. Reactions
were initiated upon addition of 3.5 mM Ca2 and 42 M ATP spiked with 0.2
Ci of [32P]ATP. Samples were incubated at 30°C for 20 min and then
blocked with acidified chloroform:methanol (1:1 vol/vol). The organic layer
was isolated, dried and fractionated by TLC. Radiolabeled phosphoinositides
were visualized by autoradiography and quantified by densitometry.
Immunocytochemistry
Cells seeded on 18-mm polylysine coated coverslips were fixed with 4%
paraformaldehyde for 20 min, washed in PBS and then blocked for 1 h in PBS
containing 3% goat serum, 0.05% Triton X-100. In some experiments, cells
were treated with wortmannin (Sigma) for 15 min before fixation. Indicated
antibodies (all 1:500) were then incubated overnight at 4°C, washed with PBS
and revealed using relevant secondary conjugated antibody (Alexa488 and
Texas Red; 1:200; Molecular Probes) for 40 min at room temperature in the
dark followed by washing and mounting with mowiol (Arco). Samples were
imaged by confocal microscopy (LSM 510; Zeiss). To illustrate the degree of
colocalization, scatter diagrams were produced using LSM 510 software plot-
ting the pixels intensity in the red and green channels (x and y coordinates
respectively). Double stained pixels (intensity 100 A.U.) of the optical sec-
tions were highlighted in white.
Constructs
EE tagged PI3K-C2 cDNA in pBluescript vector was used as a template for
site directed mutagenesis (QuickChange, Stratagene). Mutant PI3K-C2 con-
tains a single amino acid substitution (R1251P). This residue lies within the
DRHNDN sequence that corresponds to the kinase motif present in mamma-
lian PI3Ks. Both wild-type and mutant were inserted in pcDNA3.1 for mam-
malian expression. GFP-2xFYVE and GFP-2xFYVEC215S from Hrs were pre-
pared accordingly to Pattni et al. (2001), whereas GST-2xFYVE was expressed
and purified as described previously (Gillooly et al., 2000).
hGH release from transfected PC12 cells
PC12 cells were routinely cultured in DMEM supplemented with 10% fetal
bovine serum, 10% horse serum. Before transfection, cells were incubated in
DMEM antibiotic-free medium for 2 h and in OPTIMEM (InVitrogen) for 30
min. Mammalian expression vectors (1.25 g/well) and pXGH5 encoding
hGH (0.6 g/well) were cotransfected in PC12 cells with lipofectamine 2000
(InVitrogen) in OPTIMEM according to the manufacturer’s instructions.
Transfection efficiency was between 30 and 50% and more than 95% of
transfected cells coexpressed hGH and the protein of interest. 48 h after
transfection PC12 cells were briefly washed in buffer A and incubated either
in buffer A (control) or in high K buffer for 20 min. Aliquots of the super-
natant were collected and the cells detached using the remaining buffer
passing through a 25-gauge needle several times. The amount of secretion
from cotransfected cells was determined as % of total hGH/well using a hGH
radioimmunoassay kit (Nichols Institute).
Statistical analysis
Data analysis was carried out using Student’s t test. Experiments were per-
formed at least 3 times. Values are expressed as mean  SEM and data were
considered significant at **p 0.01.
RESULTS
Chromaffin cells were preincubated with either 10 nM wort-
mannin or 1 M LY294002 for 20 min and thereafter stim-
ulated by depolarisation or by carbachol. Catecholamine
secretion was unaffected by either inhibitor (see supplemen-
tary material S1). To rule out any long-term effect of PI3K
activity on this process, chromaffin cells were treated for 24 h
in culture medium with LY294002 (1 M) without signifi-
cant consequence on evoked catecholamine release (see sup-
plementary material S1). Together, these experiments seem
to exclude any direct involvement of most subtypes of PI3K
in neuroexocytosis, as previously established in neurosecre-
tory cells and synaptosomes (Wiedemann et al., 1996; Martin
et al., 1997; Wiedemann et al., 1998). However, one PI3K
isoform, type II PI3K-C2, is much less sensitive to these
Figure 1 (facing page). Effect of PI3K inhibitors on catecholamine
secretion from chromaffin cells. (A) Chromaffin cells were incubated
for 20 min with increasing concentration of inhibitors and stimu-
lated with carbachol (100 M) in the continuing presence of inhib-
itors for 20 min. (B) EE-tagged PI3K-C2 was transiently expressed
in COS cells and immunoprecipitated with anti-EE monoclonal
antibodies followed by protein A-Sepharose. PI3K-C2 was eluted
with an excess of EE peptide and aliquots treated at 4°C for 5 h with
either preimmune serum or anti-PI3K-C2 antibody. This mixture
was then incubated with PtdIns in a standard lipid kinase assay as
described in the method section. Phosphorylated products were
visualized by autoradiography after separation by TLC. The exper-
iment was done in triplicate. (C) Chromaffin cells were permeabil-
ized with 20 M digitonin in Ca2- and ATP-free KGEP buffer alone
or containing affinity purified anti-PI3K-C2 (0.38 g/ml) or pre-
immune serum (88 g/ml) for 10 min. (D) GST-PI3K-C2 (5 g/ml)
or GST alone (5 g/ml) were preincubated for 30 min with or
without 0.38 g/ml anti-PI3K-C2 before addition to permeabilized
chromaffin cells for 10 min. (E) Cells were preincubated with
LY294002 (50 M) for 20 min before permeabilization in the con-
tinuing presence of inhibitors. (C, D, E) The supernatant was re-
moved and replaced by stimulation KGEP buffers as indicated in the
continuing presence of antibodies/inhibitors for 5 min. (A, C, D, E)
Aliquots were removed and assayed fluorimetrically for catechol-
amine content (n  4 experiments; ** t test p 0.01).
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inhibitors (Domin et al., 1997). Chromaffin cells were pre-
treated with increasing concentrations of LY294002 or wort-
mannin before stimulation. Both inhibitors impaired carba-
chol-induced secretagogue activity in a dose-dependent
manner at concentrations that are known to inhibit PI3K-
C2 (Figure 1A). However, at these concentrations LY294002
and wortmannin have been reported to inactivate other
kinases (Okkenhaug and Vanhaesebroeck, 2001). To exclude
this possibility, cells were treated with LY303511, an ana-
logue of LY294002 that does not inhibit PI3K. Carbachol-
evoked secretion was not blocked by 50 M of LY303511,
whereas 50 M LY294002 drastically reduced this response
(Figure 1A), suggesting a role for PI3K-C2 during neuro-
exocytosis.
Before exocytosis, neurosecretory vesicles are thought to
be mobilized from a reserve pool to the plasma membrane,
where they can dock and enter the readily releasable pool
(Rizzoli and Betz, 2002; Burgoyne and Morgan, 2003; Dun-
can et al., 2003). To acquire fusion competence, docked ves-
icles need to be primed, a process requiring ATP (Bittner
and Holz, 1992; Osborne et al., 2001; Rettig and Neher, 2002).
Permeabilized chromaffin cells are a useful system to inves-
tigate these later steps since Ca2 alone triggers a rapid but
limited secretion of catecholamine from large dense core
vesicles (LDCV) while in the presence of ATP, Ca2-induced
secretion is increased due to recruitment, priming and fu-
sion of additional LDCV (Bittner and Holz, 1992). Addition
of an excess of affinity-purified PI3K-C2 antibody to recom-
binant PI3K-C2 inhibits its kinase activity (Figure 1B) in
vitro. We investigated the involvement of PI3K-C2 in neu-
rosecretion by testing the effect of this blocking antibody on
LDCV exocytosis in digitonin-permeabilized chromaffin
cells. Cells were preincubated for 10 min with anti-PI3K-C2
or preimmune serum and then stimulated for 5 min with
each of four indicated intracellular buffers in the continuing
presence of antibody. Anti-PI3K-C2 selectively reduced the
Ca2 plus ATP-dependent catecholamine secretion to the
level obtained with Ca2 alone, whereas the preimmune
serum had no effect (Figure 1C). Importantly, the Ca2-
dependent ATP-independent step was unaffected. To assess
the specificity of this antibody on priming, anti-PI3K-C2
was preincubated with a molar excess of GST alone or GST
fused with the N-terminal portion of PI3K-C2. Preincuba-
tion of anti-PI3K-C2 with the cognate GST-fusion protein
rescued priming elicited by ATP in the presence of Ca2
(Figure 1D), whereas anti-PI3K-C2 pretreated with GST
alone still inhibited priming. These results demonstrate that
by specifically inhibiting PI3K-C2, this antibody is capable
of interfering with the ATP-dependent priming step of cat-
echolamine secretion in chromaffin cells. Although alterna-
tive explanations are possible, the strong inhibition seen on
priming by treatment with the anti-PI3K-C2 antibodies
might be explained by a dominant-negative effect of the
PI3K-C2-antibody complex or envisaging the requirement
of a threshold PI3K activity during this process.
Because high concentrations of PI3K inhibitors block car-
bachol-evoked catecholamine release from intact chromaffin
cells (Figure 1A), we examined whether this block was gen-
erated at the ATP-dependent level (priming) or at the final
Ca2-dependent step of exocytosis. LY294002 (50 M) re-
duced the ATP- and Ca2-dependent secretion to that of
Ca2 alone (Figure 1E), consistent with the effect of anti-
PI3K-C2 antibody. Wortmannin (10 M) had a similar
inhibitory effect but also reduced the Ca2-dependent secre-
tion, suggesting the involvement of other kinases in the
latter step of exocytosis (data not shown). In addition, per-
meabilized chromaffin cells were treated with both anti-
PI3K-C2 and LY294002 (50 M) to test whether an additive
effect could be detected. As shown in Figure 1E, anti-PI3K-
C2 antibodies and LY294002 alone and in combination give
rise to similar inhibition of ATP-dependent priming, indi-
cating that these two reagents act on the same pathway. The
blockade of priming by high concentrations of PI3K inhibi-
tors and anti-PI3K-C2 is likely to result from an inhibition
Figure 2. PI3K-C2 associates with secre-
tory granule fraction in chromaffin cells.
Equivalent amount of proteins of the indi-
cated fractions (Gasman et al., 1998) were sep-
arated by SDS-PAGE and immunoblotted
with the indicated antibodies.
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of PtdIns3P synthesis. We attempted to test this hypothesis
by performing the experiment in the presence of [32P]-ATP
and 1 M LY294002 to inhibit other PI3K, and then analyz-
ing cellular lipids by HPLC. However, the low level of [32P]
incorporation into PtdIns3P under these conditions suggests
that the pool of PtdIns3P synthesized by PI3K-C2 in chro-
maffin cells is too small to be measured with the available
analytical techniques.
Western blotting using anti-PI3K-C2 antibodies (Arcaro
et al., 2000) demonstrated that PI3K-C2 is present in chro-
maffin cell extracts and enriched in the chromaffin granule
fraction (Figure 2). In these samples, the anti-PI3K-C2 an-
tibody detected a single band with an apparent molecular
weight of 200 kDa, further confirming its specificity. Impor-
tantly, no PI3K-C2 was detected in the cytosol, suggesting
that in chromaffin cells this enzyme is selectively recruited to
intracellular membranes including secretory granules. Syn-
aptotagmin I (Syt I), an integral granule membrane protein,
was similarly enriched in the chromaffin granule fraction
(Figure 2). Control experiments with anti-early endosomal
marker 1 (EEA1) and anti-clathrin antibodies demonstrated
that there was no detectable contamination of the granule
fraction with clathrin-coated vesicles and early endosomes
(Figure 2), two compartments which have been previously
shown to recruit PI3K-C2 (Domin et al., 1997).
PI3K-C2 was found on a discrete population of vesicles
in chromaffin cells (Figure 3A, B). These organelles repre-
sented a subpool of secretory granules as shown by colocal-
ization with Syt I (Walch-Solimena et al., 1993) (Figure 3A;
see 3-D reconstruction in supplementary material S2). Con-
focal analysis revealed that 40.3  4.0% of the vesicles pos-
itive for Syt I were also PI3K-C2-positive, whereas 36.2 
5.1% of the vesicles immunostained for PI3K-C2 were also
positive for Syt I. To identify which subset of secretory
granules recruits PI3K-C2, coimmunostaining experiments
were performed using a monoclonal antibody (mAb) against
the processed form of secretogranin (P18). This fragment is
only present in mature secretory granules (Wendler et al.,
Figure 3. PI3K-C2 localizes to mature secretory granules. Fixed chromaffin cells were immunostained with anti-PI3K-C2 and either
anti-Syt I (A) or anti-P18 antibodies (B) and imaged by confocal microscopy. Colocalized pixels (100 a.u.) were highlighted (in white) in the
z-stack series of optical sections shown below. Scale bar: 10 m.
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2001). 73.7  6.4% of the P18-positive granules were also
positive for PI3K-C2, and 59.7  4.4% of the PI3K-C2
positive organelles were coimmunostained by P18 (Figure
3B). These experiments demonstrated that PI3K-C2 is re-
cruited to the membrane of mature secretory granules prox-
imal to the plasma membrane.
To further examine the role of PI3K-C2 in exocytosis, we
switched to a pheochromocytoma cell-line (PC12), where
plasmids of interest can be cotransfected with a reporter
plasmid encoding human growth hormone (hGH). hGH is
stored in LDCV (Schweitzer and Kelly, 1985) and is released
upon stimulation, serving as a marker for secretion in co-
transfected cells (Holz et al., 2000). Plasmids encoding EE-
tagged wild-type PI3K-C2 (PI3K-C2-wt) and PI3K-C2
containing a point mutation in the catalytic domain (PI3K-
C2-R1251P) were transfected in HEK cells where both pro-
teins were expressed at comparable levels (Figure 4). To
confirm that PI3K-C2-R1251P is catalytically inactive, wild-
type and mutant kinases were immunoprecipitated with
anti-EE tag antibodies (Figure 4A) and tested in a lipid
kinase assay using PtdIns as a substrate. A major band
corresponding to PtdIns3P was synthesized by immunopre-
cipitates from PI3K-C2-wt transfected cells (Figure 4B), as
confirmed by HPLC (Domin et al., 1997). In contrast, immu-
noprecipitates from cells transfected with PI3K-C2-R1251P
or control untransfected cells showed no such activity (Fig-
ure 4B).
The sensitivity of hGH secretion to PI3K inhibitors was
tested in PC12 cells by incubation with increasing concen-
trations of wortmannin, LY294002 and its inactive analogue
LY303511 for 20 min before stimulation. Both inhibitors
block hGH exocytosis at very high concentrations (Figure
5A), reminiscent of their effect on catecholamine secretion
from chromaffin cells (Figure 1). Importantly, LY303511 did
not alter hGH secretion even at the highest concentration
tested (50 M; Figure 5A).
PI3K-C2-wt, PI3K-C2-R1251P or vector alone were then
cotransfected with hGH in PC12 cells for 48 h. Immunostain-
ing using anti-hGH monoclonal antibodies demonstrated
that overexpression of either PI3K-C2-wt or PI3K-C2-
R1251P did not affect the level of expression nor the local-
ization of hGH in these cells (Figure 5B). In control samples,
depolarisation in the presence of Ca2 triggered the secre-
tion of 11.7  0.3% of the expressed hGH (Figure 5C).
Overexpression of PI3K-C2-wt enhanced hGH secretion to
17.5 0.3%, indicating that PI3K-C2 has a facilitating effect
on LDCV exocytosis. In contrast, coexpression of the cata-
lytically-inactive PI3K-C2-R1251P abolished depolarisa-
tion-induced hGH release (5.4  0.4%; compared with 5.6 
0.4% of unstimulated cells), indicating that PI3K-C2 activ-
ity is required for LDCV secretion (Figure 5C).
To exclude the possibility that overexpression of PI3K-
C2-wt alters the levels of multiple phosphoinositides other
than PtdIns3P, we labeled transiently-transfected PC12 cells
with [2-3H]inositol, extracted the lipids and analyzed the
cellular content of phosphoinositides by HPLC. We ob-
served no changes in the steady state levels of PtdIns4P or
PtdIns(4,5)P2 in cells expressing either wild-type or inactive
PI3K-C2 (see supplementary material S3). In contrast, cells
expressing PI3K-C2-R1251P showed a decrease in the
steady-state levels of PtdIns3P and PtdIns(3,4,5)P3. Notably,
as the efficiency of transfection in this experiment was low,
the decrease in the 3-phosphorylated inositides observed is
probably underestimated. In contrast, expression of PI3K-
C2-wt did not produce dramatic changes in PtdIns3P and
PtdIns(3,4,5)P3.
The effect of PtdIns3P sequestration on neuroexocytosis
was then assessed by cotransfection of PC12 cells with hGH
and GFP-2xFYVE. To exclude that overexpression of GFP-
2xFYVE or its PtdIns3P binding-impaired mutant (GFP-
2xFYVEC215S) (Pattni et al., 2001) was altering hGH process-
ing, its distribution in secretory granules was assessed by
immunocytochemistry. As shown in Figure 6A, hGH immu-
noreactivity appeared indistinguishable in single- (hGH
only) and double-transfected (hGH and GFP-2xFYVE or
GFP-2xFYVEC215S) PC12 cells. However, when these cells
were stimulated by depolarisation, GFP-2xFYVE overex-
pression blocked hGH release (Figure 6B). In contrast, GFP-
2xFYVEC215S mutant had no effect on secretion (Figure 6B).
Finally we tested whether 2xFYVE domain-induced seques-
tration of PtdIns3P was capable of selectively blocking ATP-
dependent priming in chromaffin cells. Digitonin-permeabi-
Figure 4. Expression and kinase activity of PI3K-C2-wt and mu-
tant PI3K-C2-R1251P. HEK 293 cells were transfected with control
vector, PI3K-C2-wt or mutant PI3K-C2-R1251P. After 72 h, re-
combinant enzymes were isolated from cell lysates using an anti-EE
mAb and protein A-sepharose beads and blotted with anti-EE an-
tibody (A) or used in a lipid kinase assay using PtdIns as substrate
(B).
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lized chromaffin cells were incubated with either bacterially-
expressed GST-2xFYVE or GST alone (17 M) for 15 min
before Ca2-dependent stimulation of exocytosis. Our data
indicate that 2xFYVE domain does indeed inhibit Ca2- and
ATP-dependent exocytosis to the level observed for Ca2
alone stimulation (Figure 6C). Altogether, these findings
demonstrate that the maintenance of a PtdIns3P pool on
secretory granules is necessary for neurosecretion.
DISCUSSION
To our knowledge, this study reveals for the first time a
major role for PI3K-C2 in the ATP-dependent priming of
neurosecretory vesicles - a crucial step during which vesicles
acquire the competence to fuse with the plasma membrane
upon Ca2 entry.
Differential sensitivity to PI3K inhibitors suggest a role
for PI3K-C2 in neuroexocytosis
Wortmannin and LY294002 are two cell permeable inhibi-
tors possessing good selectivity and potency for PI3K types
I, II and III (Okkenhaug and Vanhaesebroeck, 2001). One
advantage of LY294002 over wortmannin is its longer half-
life (Okkenhaug and Vanhaesebroeck, 2001), which allowed
not only acute but also long-term inhibition of PI3K activi-
ties, a feature used in our experiment to address possible
long-term effects of 3-phosphorylated lipids on secretion. In
our hands, neither acute nor chronic exposure to PI3K in-
hibitors modified catecholamine secretion from chromaffin
cells. Nevertheless neurosecretion from chromaffin cells was
sensitive to both PI3K inhibitors at high concentrations. A
recent study has highlighted a role for PI3K during synaptic
vesicle exocytosis via a direct interaction of p85 with synap-
sin (Cousin et al., 2003). Interestingly, the concentration of
PI3K inhibitors used in this study far exceeded that usually
needed to inhibit PI3K type I.
These results have shifted our attention to PI3K-C2,
which is more than ten times less sensitive to both inhibitors
(Domin et al., 1997). PI3K-C2 is expressed in chromaffin
cells, where it was found on a subpopulation of chromaffin
granules. The colocalization of PI3K-C2 with the processed
form of secretogranin (Wendler et al., 2001) on vesicles abut-
ting the plasma membrane provides the first demonstration
that PI3K-C2 is present on mature secretory granules.
However, PI3K-C2 is selectively recruited on a subpool of
secretory granules as PI3-kinase C2 colocalization with this
LDCV marker is partial. Although we cannot formally ex-
clude that our anti-PI3K-C2 antibody is capable of recog-
nizing only a fraction of PI3K-C2-positive structures, the
use of a polyclonal antibody detecting multiple PI3K-C2
epitopes makes the above-mentioned possibility unlikely.
Furthermore, the percentage of the granules stained was
remarkably constant in different sets of experiments where
Figure 5. PI3K-C2 enhances hGH secretion from PC12 cells
whereas its catalytically-inactive mutant is inhibitory. (A) PC12 cells
transfected with a human growth hormone (hGH)-expressing vec-
tor (pXGH5) were treated with indicated concentrations of wort-
mannin, LY294002 or its inactive analogue LY303511 for 20 min
prior stimulation with high K buffer A containing Ca2 for 20 min
in the continuous presence of the inhibitors. (B, C) PC12 cells were
cotransfected with pXGH5 and with wild-type PI3K-C2 or PI3K-
C2-R1251P. (B) Cells were fixed and coimmunostained for PI3K-
C2 and hGH. Scale bar: 10 m. (C) Transfected PC12 cells were
stimulated in high K buffer A containing Ca2 for 20 min. (A, C)
Aliquots were removed and assayed for hGH secretion, ** p 0.01).
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antibody concentration and protocols of fixation and perme-
abilization varied widely.
In fibroblasts, PI3K-C2 has been shown to be enriched on
the TGN and clathrin-coated vesicles (Arcaro et al., 2000). On
the TGN, PtdIns3P has been shown to be required for the
formation of constitutive transport vesicles (Jones and How-
ell, 1997). In chromaffin cells, PI3K-C2 may therefore con-
trol the biogenesis of secretory vesicles at the level of the
TGN as well as later stages. In these cells, PI3K-C2 partially
colocalizes with clathrin-coated vesicles (data not shown).
Because clathrin can regulate PI3K-C2 enzymatic activity
(Gaidarov et al., 2001), PI3K-C2 could also be involved in
Figure 6. PtdIns3P is required for neurosecretion in PC12 cells. (A, B) PC12 cells cotransfected with pXGH5 encoding hGH and GFP-2xFYVE
or GFP-2xFYVEC215S for 48 h and then immunostained for hGH (A). Insets show high-magnification details of the hGH-containing structures
(white rectangle). Scale bar: 10 m. (B) Cotransfected PC12 cells were briefly washed and stimulated in high K buffer A containing Ca2
for 20 min. Aliquots were removed and assayed for hGH secretion, which was expressed as a percentage of the total hGH content. (C)
Chromaffin cells were permeabilized with 20 M digitonin in Ca2- and ATP-free KGEP buffer in the presence or absence of bacterially
expressed GST or GST-2xFYVE (17 M) and incubated for 15 min. The supernatant was then removed and replaced by stimulation KGEP
buffers as indicated, in the continuing presence of recombinant proteins for 5 min. Aliquots were removed and assayed fluorimetrically for
catecholamine content (n  4 experiments, ** p 0.01).
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the clathrin-dependent budding that is required for granule
maturation (Tooze et al., 2001). Therefore, PI3K-C2 may
play pleiotropic roles in regulating the function of secretory
and recycling vesicles in neurosecretory cells. This pleiot-
ropy is apparently shared by PI4K II, which was recently
shown to regulate vesicle budding from the Golgi in nonse-
cretory cells (Wang et al., 2003), as well as being required for
synaptic vesicle exocytosis (Guo et al., 2003).
Involvement of PI3K-C2 enzymatic activity in
neurosecretion
Two distinct strategies were used to investigate the role of
PI3K-C2 and its enzymatic product(s) in secretion. First, we
exploited an antibody-based approach in permeabilized
chromaffin cells to determine whether sequestration of PI3K-
C2 interferes with catecholamine release. This method al-
lowed us to show that PI3K-C2 antibodies specifically im-
pair the ATP-dependent step of secretion, but not the Ca2-
dependent fusion of already primed LDCV with the plasma
membrane. Moreover, this inhibitory effect suggests that the
PtdIns3P generated by PI3K-C2 on mature secretory gran-
ules might be directly responsible for the acquisition of their
fusion-competence. The ATP-dependent step preceding
Ca2-dependent fusion comprises both recruitment of
LDCV to the plasma membrane and priming (Dunn and
Holz, 1983; Sarafian et al., 1987). PI3K-C2 activity might be
important for either one or both processes. For example, it
could be implicated in ARF6-dependent vesicular move-
ments via cortical F-actin, which involves the Arp2/3 com-
plex, tyrosine kinase activity, PLD and 3-phosphoinositides
(Schafer et al., 2000; Vitale et al., 2001).
Our second strategy was to transiently transfect PC12 cells
with PI3K-C2 or its catalytically-inactive mutant in con-
junction with hGH. Because hGH is stored in secretory
vesicles (Schweitzer and Kelly, 1985), this method has been
successfully used to elucidate the role played in neurosecre-
tion by many proteins of interest (Holz et al., 2000). The
enhancement of evoked secretion following overexpression
of wild-type PI3K-C2 suggests that PI3K-C2 activity con-
trols the progression of LDCV toward a fusion-competent
state. Importantly, transient expression of a catalytically-
inactive PI3K-C2 mutant completely abolished hGH secre-
tion, demonstrating that PI3K-C2 is essential to the release
mechanism. Although the molecular mechanism responsible
for this phenomenon remains elusive, it is possible that the
overexpression of the catalytically-inactive mutant may lead
to the sequestration of PI3K-C2 regulators resulting in an
inhibition of docking and/or priming.
PI3K-C2 catalyzes the production of PtdIns3P in vivo
(Domin et al., 1997 and this study). In addition to its well-
established role in endosomal traffic (Gillooly et al., 2001),
PtdIns3P, produced by the class II PI3K-C2, can also act as
a signaling molecule, with levels increasing upon lysophos-
phatidic acid stimulation during cell migration (Maffucci et
al., 2005). Furthermore, this agonist-stimulated pool of
PtdIns3P is on the plasma membrane. Thus, multiple intra-
cellular pools of PtdIns3P exist in different cell-types. Our
results add to this expanding list by identifying a novel pool
of PtdIns3P in chromaffin and PC12 cells that is required for
exocytosis of LDCV.
The ATP-dependent priming process remains quite enig-
matic since little is known about the dynamics of the molec-
ular events involved. Several proteins have been shown to
participate in the priming of LDCV via controlling SNARE
complex formation. A main player in this process is Munc18,
which holds syntaxin in a closed conformation thereby pre-
venting the assembly of the SNARE bundle. The dissociation
of Munc18-syntaxin complex is believed to have an impor-
tant role in the early events of priming (Misura et al., 2000).
In contrast, Munc13–1 overexpression accelerates the rate of
LDCV priming by promoting the open conformation of syn-
taxin (Ashery et al., 2000). Acetylcholine-SNAP and NSF
were also shown to increase the priming rate (Xu et al., 1999).
Several kinases such as PKA, protein kinase C (PKC), Ca2-
regulated myosin light chain kinase have been shown to
modulate neurotransmitter release (Kumakura et al., 1994;
Capogna et al., 1995; Mochida, 1995). Finally, PtdIns(4,5)P2
formation by the conjoint ATP-dependent activities of PI4K
and PI4P5K has been shown to be required for LDCV prim-
ing (Martin et al., 1997) In contrast to its role in signal
transduction, where it acts as a substrate for the generation
of diacylglycerol and InsP3, PtdIns(4,5)P2 itself is likely to
serve as a membrane anchor or modulator for several pro-
teins of the secretory apparatus, such as synaptotagmins and
CAPS (Walent et al., 1992; Schiavo et al., 1996). PtdIns(4,5)P2
has also been shown to be required for synaptic vesicle
recycling (Cremona and De Camilli, 2001; Bai et al., 2004).
Interestingly, PtdIns(4,5)P2 was found predominantly asso-
ciated with the plasma membrane in chromaffin cells (Holz
et al., 2000) and is absent from vesicular structures, indicat-
ing that a precise mechanism regulating its synthetic ma-
chinery exists in neurosecretory cells. To our knowledge,
our findings provide the first evidence that phosphoino-
sitides other than PtdIns(4,5)P2 may play a role in Ca2-
regulated secretion and suggest that PtdIns phosphorylation
by PI3K-C2 leading to PtdIns3P production is an essential
step during priming of secretory vesicles. How does
PtdIns3P control priming? To answer this question, a crucial
step in future investigations will be the identification of
PtdIns3P effectors, which bind to mature secretory granules
upon PI3K-C2 recruitment.
In conclusion, we have demonstrated a critical function
for PI3K-C2 and its enzymatic product, PtdIns3P, during
the ATP-dependent priming step preceding Ca2-depen-
dent exocytosis. The generation of PtdIns3P by PI3K-C2 on
the vesicular membrane adds to the repertoire of phospho-
inositide synthetic processes, which are crucial for regulated
secretion. In this light, different phosphoinositides may
carry out distinct functions in a single trafficking step, re-
vealing a more complex level of regulation for the acquisi-
tion of fusion-competence.
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